You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Compensated cirrhosis

Showing 1 - 25 of 2,204
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cirrhosis, Decompensated Cirrhosis, Portal Hypertension Trial (EUS)

Not yet recruiting
  • Cirrhosis
  • +2 more
  • EUS
  • (no location specified)
Nov 13, 2022

Primary Biliary Cholangitis Trial in Xi'an (Fenofibrate 200mg, Placebo, UDCA)

Recruiting
  • Primary Biliary Cholangitis
  • Fenofibrate 200mg
  • +2 more
  • Xi'an, Shaanxi, China
    Xijing Hospital
Mar 3, 2023

Primary Biliary Cholangitis Trial in United States (Seladelpar 10 mg, Placebo)

Recruiting
  • Primary Biliary Cholangitis
  • Seladelpar 10 mg
  • Placebo
  • Lancaster, California
  • +4 more
Sep 26, 2023

Compensated Cirrhosis, Decompensated Cirrhosis Trial in New Delhi (Metformin, Sitagliptin, Dapagliflozin)

Not yet recruiting
  • Compensated Cirrhosis
  • Decompensated Cirrhosis
  • New Delhi, Delhi, India
    Dr Rakesh Kumar Jagdish
Nov 23, 2023

Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

Not yet recruiting
  • Hepatitis C
  • Cirrhosis
  • (no location specified)
Jul 20, 2022

Obesity, Compensated Cirrhosis, Sarcopenia Trial (Continuous Energy Restriction (CER), Alternate Day Modified Fasting (ADMF),

Not yet recruiting
  • Obesity
  • +2 more
  • Continuous Energy Restriction (CER)
  • +6 more
  • (no location specified)
May 4, 2022

Based on Spleen Stiffness, Liver Stiffness and Platelets for

Recruiting
  • Portal Hypertension
  • Hepatic venous pressure gradient
  • Lanzhou, Gansu, China
  • +4 more
May 27, 2022

NASH - Nonalcoholic Steatohepatitis Trial in Chandler (BIO89-100)

Completed
  • NASH - Nonalcoholic Steatohepatitis
  • Chandler, Arizona
    89bio Clinical Study Site
Feb 28, 2022

Baveno VI Criteria in Dynamic Monitoring of High-risk Varices in

Not yet recruiting
  • Cirrhosis
  • +2 more
  • Complete blood count
  • +2 more
  • (no location specified)
Sep 10, 2022

NASH, Cirrhosis, Liver Trial in North Little Rock (Resmetirom)

Not yet recruiting
  • NASH
  • Cirrhosis, Liver
  • North Little Rock, Arkansas
    Arkansas Gastroenterology
Aug 11, 2022

Cirrhosis Trial in United States (Placebo Oral Tablet, Simvastatin 40mg)

Recruiting
  • Cirrhosis
  • Placebo Oral Tablet
  • Simvastatin 40mg
  • San Francisco, California
  • +11 more
Jun 16, 2022

Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)

Completed
Has Results
  • Hepatitis C Virus Infection
  • +2 more
  • (no location specified)
Jul 9, 2021

Cirrhosis, Liver, Liver Fibrosis, Ascites Hepatic Trial in Chandler, Rochester (PHIN-214 Subcutaneous injection)

Recruiting
  • Cirrhosis, Liver
  • +2 more
  • PHIN-214 Subcutaneous injection
  • Chandler, Arizona
  • +1 more
Aug 4, 2022

Non-alcoholic Steatohepatitis, Fatty Liver, Fibrosis, Liver Trial in San Antonio (Nitazoxanide 500mg BID)

Completed
Has Results
  • Non-alcoholic Steatohepatitis
  • +3 more
  • Nitazoxanide 500mg BID
  • San Antonio, Texas
    Pinnacle Clinical Research
Jun 29, 2022

Esophageal Varices in Non-Alcoholic Fatty Liver Disease With

Not yet recruiting
  • Esophageal Varices
  • +2 more
  • Reviewing records retrospectively of patients undergoing screening endoscopy
  • Al Ain, Abu Dhabi, United Arab Emirates
    Internal Medicine, College of Medicine and Health Sciences
Aug 3, 2022

Liver and Spleen Stiffness Measured by 2D-SWE for Diagnosis of

Recruiting
  • Liver Fibrosis
  • Liver Cirrhosis
  • Diagnostic Test: Transient elastography (TE) and 2D-shear wave elastography (2D-SWE)
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital, Sun Yat-sen University
Nov 19, 2023

Primary Sclerosing Cholangitis, Compensated Cirrhosis Trial in United States (CILO)

Completed
  • Primary Sclerosing Cholangitis
  • Compensated Cirrhosis
  • Chandler, Arizona
  • +15 more
Sep 27, 2021

Intestinal Permeability in Liver Cirrhosis Using Confocal

Terminated
  • Cirrhosis, Liver
  • Fluorescein
  • Mainz, Germany
    University Medical Center of the Johannes Gutenber Univeristy
Mar 28, 2022

Liver and Spleen Stiffness Measured by TE and 2D-SWE for

Recruiting
  • Liver Cirrhosis
  • +2 more
  • Transient elastography (TE) and 2D-shear wave elastography (2D-SWE)
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital, Sun Yat-sen University
Nov 16, 2023

Proportion of Hepatic Toxicity and All Adverse Drug Reactions in

Completed
  • Hepatitis C
    • Tokyo, Japan
      Local Institution
    Feb 7, 2022

    Liver and Spleen Stiffness Measured by TE and 2D-SWE for

    Recruiting
    • Liver Cirrhosis
    • +2 more
    • Diagnostic Test: Transient elastography (TE) and 2D-shear wave elastography (2D-SWE)
    • Zhuhai, Guangdong, China
      The Fifth Affiliated Hospital, Sun Yat-sen University
    Nov 19, 2023

    Hepatitis B, Chronic Trial in China (Tenofovir disoproxil fumarate)

    Completed
    Has Results
    • Hepatitis B, Chronic
    • Tenofovir disoproxil fumarate
    • Guangzhou, Guangdong, China
    • +18 more
    Nov 26, 2021

    High-risk Gastroesophageal Varices in Compensated Cirrhosis

    Recruiting
    • Compensated Cirrhosis
    • esophagogastroduodenoscopy
    • Hefei, Anhui, China
    • +13 more
    Aug 16, 2021

    Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • Compensated Cirrhosis
    • ABT-450/r/ABT-267, ABT-333
    • Ribavirin (RBV)
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C, Chronic Hepatitis B Trial in Beijing (Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir)

    Recruiting
    • Chronic Hepatitis C
    • Chronic Hepatitis B
    • Tenofovir Alafenamide 25 MG
    • Sofosbuvir / Velpatasvir
    • Beijing, Beijing, China
      Peking University First Hospital
    Aug 2, 2021